Staphylococcus Aureus Infection Clinical Trial
Official title:
Epidemiology of Rural MRSA : Is Livestock Contact a Risk Factor?
Background:
- MRSA is a type of bacteria that causes serious health problems. It can cause severe
infections and is difficult to treat. MRSA has been found in a high number of people who work
with some kinds of livestock, such as pigs. Researchers want to study people in rural areas,
where more people work with or around livestock. They want to see if MRSA is more common or
causes more serious infections in these areas.
Objectives:
- To look at the relationship between livestock handling (especially pigs) and MRSA bacteria
in people in rural areas.
Eligibility:
- Participants in the Agricultural Health Study in Iowa, including those who are exposed
to livestock.
- Healthy volunteers who are not exposed to livestock.
Design:
- This study requires an initial visit and monthly follow-up surveys for 18 months.
- At the first visit, participants will have throat and nose swabs to collect cell and
bacteria samples. They will also complete a questionnaire about their health habits.
Other questions will ask about any work that brings them into contact with livestock
like cows, pigs, or chickens.
- Every month for the next 17 months, participants will complete another questionnaire to
record any changes in their health and livestock contact information. They will also
collect throat and nose swabs. They will send the questionnaires and the swabs to the
study researchers.
- Participants will be paid for the first visit and for every monthly survey and swab
collection they return.
- No treatment will be given as part of this protocol.
The goal of this study is to understand the epidemiology of antibiotic-resistant S. aureus,
including methicillin resistant S. aureus (MRSA), outside of the hospital environment. Our
objective is to characterize the epidemiology of S. aureus in the rural community, focusing
on persons who have contact with livestock. We will achieve this by carrying out two parallel
prospective cohort studies in Iowa, examining 1) individuals enrolled in the Agricultural
Health Study, including those who raise swine; and 2) a matched population-based group with
no livestock exposure. We will partner with the state s microbiological diagnostic
laboratories in order to collect isolates from the symptomatic S. aureus infections. Our
central hypothesis is that individuals working in close proximity to livestock and poultry
are at risk of occupational exposure to MRSA. We further hypothesize that farmers in contact
with livestock (swine in particular) will be more likely to be colonized with
swine-associated S. aureus strains than are individuals without contact. Finally, we expect
to see both typical human strains of S. aureus (including USA300) as well as
animal-associated strains (such as ST398) causing infections in Iowans. Our rationale is that
successful completion will provide opportunities to institute an early warning system to
evaluate emerging S. aureus strains, allowing for potential interventions prior to widespread
dissemination in the human population. We will test our central hypothesis and accomplish the
objective of this application by pursuing the following specific aims:
1. Establish the prevalence, molecular subtypes, and antibiotic resistance profiles of S.
aureus in populations of rural Iowans, and determine risk factors for colonization. We
hypothesize that individuals in contact with swine will be more likely to carry MRSA
than individuals lacking such exposure; that swine workers will more frequently be
colonized with swine-associated strains such as ST398; and that S. aureus isolates
collected from livestock farmers will more frequently demonstrate resistance to
antibiotics including methicillin and tetracyclines than isolates collected from
individuals lacking livestock exposure.
2. Determine the incidence and molecular epidemiology of symptomatic S. aureus infections
in rural Iowans. We hypothesize that symptomatic infections will be uncommon in our
cohort relative to colonization, and that the majority of such infections will be skin
and soft tissue infections. We further hypothesize that the majority of infections in
our cohorts and elsewhere in the state will be caused by common strains (including
USA300), but that some infections will also be caused by animal-associated strains,
including ST398.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04210505 -
Nasal Decolonization of Dialysis Patients Noses
|
Phase 4 | |
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Completed |
NCT02804711 -
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
|
Phase 1 | |
Completed |
NCT02282605 -
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects
|
Phase 1/Phase 2 | |
Recruiting |
NCT06319235 -
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT06317688 -
Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis
|
Phase 1 | |
Withdrawn |
NCT02741869 -
Photodisinfection for the Decolonization of Staphylococcus Aureus in Hemodialysis Patients
|
N/A | |
Completed |
NCT03966040 -
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
|
Phase 1 | |
Completed |
NCT04803708 -
Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers
|
Phase 1/Phase 2 | |
Recruiting |
NCT05117398 -
Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
|
Phase 3 | |
Not yet recruiting |
NCT06456424 -
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
|
Phase 1/Phase 2 | |
Completed |
NCT02820883 -
A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
|
Phase 0 | |
Active, not recruiting |
NCT01879761 -
Immune Resolution After Staphylococcus Aureus Bacteremia
|
||
Recruiting |
NCT00532324 -
Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns
|
N/A | |
Completed |
NCT04503252 -
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
|
||
Recruiting |
NCT06368856 -
Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study
|
Phase 1 | |
Not yet recruiting |
NCT05899140 -
Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT01792804 -
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
|
Phase 3 | |
Enrolling by invitation |
NCT04897971 -
Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections
|
||
Completed |
NCT00572910 -
A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)
|
Phase 2 |